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ABSTRACT
Numerous transgenic and knockout mouse models of
human hereditary neuropathies have become available
over the past decade. We describe a simple, reproducible,
and safe biopsy of mouse skin for histopathological evalua-
tion of the peripheral nervous system (PNS) in models of
hereditary neuropathies. We compared the diagnostic out-
come between sciatic nerve and dermal nerves found in
skin biopsy (SB) from the hind foot. A total of ﬁve animal
models of different Charcot-Marie-Tooth neuropathies, and
one model of congenital muscular dystrophy associated
neuropathy were examined. In wild type mice, dermal
nerve ﬁbers were readily identiﬁed by immunohistochem-
istry, light, and electron microscopy and they appeared
similar to myelinated ﬁbers in sciatic nerve. In mutant
mice, SB manifested myelin abnormalities similar to those
observed in sciatic nerves, including hypomyelination, on-
ion bulbs, myelin outfolding, redundant loops, and toma-
cula. In many strains, however, SB showed additional
abnormalities—ﬁber loss, dense neuroﬁlament packing
with lower phosphorylation status, and axonal degenera-
tion—undetected in sciatic nerve, possibly because SB
samples distal nerves. SB, a reliable technique to investi-
gate peripheral neuropathies in human beings, is also use-
ful to investigate animal models of hereditary neuropa-
thies. Our data indicate that SB may reveal distal axonal
pathology in mouse models and permits sequential follow-
up of the neuropathy in an individual mouse, thereby
reducing the number of mice necessary to document pa-
thology of the PNS. V V C 2010 Wiley-Liss, Inc.
INTRODUCTION
Over the past several years, there has been huge pro-
gress in generating transgenic and knockout mice that
model aspects of human hereditary neuropathies (Sherer
and Wrabetz, 2008). Animal models not only provide for-
mal proof-of-concept for the genetic cause of disease, but
they are also important to investigate its progression at
the histological level, and its molecular pathogenesis.
Transgenic animal models have become essential for
exploring novel therapies in Charcot-Marie-Tooth (CMT)
neuropathy (Nave et al., 2007).
In addition to the behavioral and functional tests, histo-
logical examination of the peripheral nervous system
(PNS) is of great importance. Morphological analyses of
myelinated nerves have been primarily performed on sci-
atic nerves. These studies require a surgical approach, and
can only be obtained by killing the animals. The study of
neuropathy evolution requires time-consuming and expen-
sive analyses of numerous animals. Thus, a more efﬁcient
method to evaluate nerve abnormalities by serial analyses
of the same animal would be advantageous. Another main
limit is that sciatic nerve is a proximal nerve. In inherited
peripheral neuropathies, the clinical and pathological
alterations are usually more severe in the distal parts of
the limbs, especially for features reﬂecting axonal damage
(Barisic et al., 2008; Kamholz et al., 2000; Krajewski et al.,
2000; Shy, 2004). Previous reports suggested that sites
other than sciatic nerve might be useful for histopathologi-
cal analysis, such as the nerves of the toes or tail (Bolino
et al., 2004; Frei et al., 1999; Wrabetz et al., 2000).
Although the analysis of toes is safe and easy, nerves are
very thin with small fascicles and only rarely could clear
signs of axonal degeneration be detected. Therefore, it is
necessary to identify a distal site of nerve examination
with the aim to detect alterations similar to those demon-
strated on sural nerve biopsy in human beings, including
ﬁber loss and axonal damage.
Although skin biopsy (SB) is rapidly becoming a recog-
nized tool for diagnosing peripheral neuropathy in
humans (Holland et al., 1997; Lauria and Lombardi,
2007; Li et al., 2005), its application has been rare in
animal models, such as surgical models of nerve injury
and models of diabetic or toxic neuropathies (Bianchi
et al., 2004; Chiorazzi et al., 2009; Giatti et al., 2009;
Navarro et al., 1997; Wu et al., 2001). Thus, we eval-
uated whether SB might be a satisfactory and reproduci-
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V V C 2010 Wiley-Liss, Inc.ble tool to identify nerve abnormalities in mouse models
of peripheral neuropathy. We chose a series of animal
models with different forms of hereditary neuropathies
in which genetic and phenotypic abnormalities have been
clearly described (Bolino et al., 2004; Bolis et al., 2005;
Nodari et al., 2008; Previtali et al., 2000; Wrabetz et al.,
2000, 2006). We performed a SB on the pad (hairless skin)
of the hind foot and compared the features of dermal
nerves to sciatic nerve. We found that dermal myelinated
nerve ﬁbers could be routinely and easily identiﬁed in
pad SB. Dermal nerves from mutants showed myelin
abnormalities qualitatively similar to those seen in sciatic
nerve. Moreover, in many cases alterations in dermal
nerves were more severe. For example, nerve ﬁbers loss
and axonal damage became apparent, even if not detected
by sciatic nerve examination. Finally, repeated SB on sin-
gle animals could allow quantiﬁcation of progression of
disease. Thus, hind foot pad SB in experimental animal
models provides the means to recognize pathology earlier
and more completely, and to follow the evolution and
effects of potential therapies on disease in single animals.
MATERIALS AND METHODS
Animals
All of the experiments with animals were performed
in the San Raffaele Scientiﬁc Institute animal house
and are covered by animal protocols approved by the
Institutional Animal Care and Use Committee. The ani-
mal models analyzed are well established and their PNS
phenotypes have been extensively characterized and
previously described (Table 1). We investigated different
models of P0-related neuropathies derived from altered
levels of Mpz expression or different Mpz point muta-
tions: Congenital Hypomyelination Neuropathy (CHN)
(Wrabetz et al., 2000), CMT1B with tomacula (P0-myc,
Previtali et al., 2000), CMT1B (S63del) or D  ej  erine-Sot-
tas Syndrome (DSS, S63C) (Wrabetz et al., 2006); one
model of CMT4B (Bolino et al., 2004; Bolis et al., 2005)
due to deletion of MTMR2 gene and one model of con-
genital muscular dystrophy associated neuropathy
(MDCN) that consists of a P0Cre/b4 integrin
f/f-dystrogly-
can
f/f, Schwann cell-speciﬁc double-null mice (Nodari
et al., 2008). Five to ten animals aged 2–12 months were
examined per genotype. We compared sciatic nerve to
SB samples collected from the ventral aspect (nonhairy
glabrous skin or pad) of the hind foot of the mouse.
Skin Biopsy Procedure
Mice were anesthetized with ketamine HCl 200 mg/kg
(injected intraperitoneally). Under an operating micro-
scope, the external skin of the foot was sterilized with
ethanol. A small sterilized skin punch, 1 mm in diame-
ter and with tip length 8 mm, was introduced perpendic-
ularly to the surface of pad skin, rotated and advanced
until reaching 3–4 mm depth (Fig. 1A). The wound was
small and was closed with a suture. We encountered no
complications and all mice survived the procedure. We
observed a fast recovery without any signs of distress.
In particular, there was no self-mutilation behavior in
the weeks following the procedure.
The size of the biopsied tissue was 1 mm in diameter,
which was adequate for histological evaluation of dermal
nerve. Only a single foot was biopsied in each procedure
and only one SB was done in each mouse. Subsequently,
the sciatic nerve from the same animal was removed fol-
lowing euthanasia. To validate the method, however, we
performed multiple biopsies (two times) in the same WT
animals at different ages (6 and 8 months).
Morphological Analysis
Histopathological analysis of sciatic and dermal
nerves of transgenic and control littermates were per-
formed as described (Lauria et al., 2005; Quattrini et al.,
1996). The SB and sciatic nerves of each line of mice
was evaluated at age 2–12 months. We performed the
following analyses: (i) an immunohistochemical
approach, using a rabbit polyclonal antibody (Ab), the
pan-axonal protein gene product 9.5 (PGP9.5) (Biogen-
esis) to identify axons in SB; an immunohistochemical
double staining to determine molecular changes of der-
mal nerves in mutant mice, using the following primary
Abs: a panel of neuroﬁlament (NF)-speciﬁc Abs, a rabbit
TABLE 1. Animal Characteristics
CMT neuropathies Animal model Phenotype References
CHN P0-overexpression Dysmyelinating neuropathy:
Hypomyelination, impaired sorting of axons
Wrabetz et al., 2000
DSS MpzS63C D  ej  erine-Sottas Syndrome:
Hypomyelination, few onion bulbs
Wrabetz et al., 2006
CMT1B MpzS63del Demyelinating neuropathy:
Hypomyelination, ﬂorid onion bulbs, demyelination
Wrabetz et al., 2006;
Pennuto et al., 2008
CMT1B (tomacula) P0-Myc Demyelinating neuropathy:
Hypomyelination, uncompaction of myelin, tomacula
Previtali et al., 2000
CMT4B MTMR2 2/2 Demyelinating neuropathy:
Myelin outfolding and recurrent loops
Bolino et al., 2004;
Bolis et al., 2005
MDCN b4integrin-Dg 2/2 Demyelinating neuropathy:
Abnormal folded myelin: infolding and
outfolding, demyelination
Nodari et al., 2008
CMT, Charcot–Marie–Tooth disease; CHN, Congenital Hypomyelination Neuropathy; DSS, D  ej  erine-Sottas Syndrome; MDCN, Congenital Muscular Dystrophy-associated
Neuropathy.
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GLIApolyclonal Ab speciﬁc for the poorly or nonphosphory-
lated NF-H (Chemicon, 1:800), a monoclonal Ab (Abcam,
1:800) speciﬁc for highly phosphorylated NF-H and NF-
M, a mouse monoclonal Ab (Immunological Science,
1:800) speciﬁc for the poorly or nonphosphorylated NF-
M; a chicken polyclonal Ab to myelin protein zero (MPZ,
Abcam, 1:100); a mouse monoclonal Ab to myelin associ-
ated glycoprotein (MAG, Millipore, 1:200) and rabbit pol-
yclonal Ab to contactin-associated protein (Caspr, 1:500)
(Peles et al., 1997); (ii) a qualitative morphological
analysis to detect the presence of axonal degeneration,
axonal regeneration, demyelination, hypomyelination,
myelin abnormalities (onion bulbs, myelin outfolding,
redundant loops, tomacula); a semiquantitative analysis
of histological changes was performed and the amount of
pathological alterations was scored: 0 5 no signs, 15
mild, 11 5 moderate, 111 5 severe; (iii) quantitative
morphometric analysis of semithin sections to quantify
the number of myelinated ﬁbers: counting of myelinated
nerve ﬁbers was performed in a blind and unbiased man-
ner on an average of three nonoverlapping microscopic
ﬁelds for CMT1B (P0-myc) and CMT4B mice at different
age (CMT1B 6 and 12 months; CMT4B 2 and 6 months; n
3 animals for time point). Fibers abnormalities were
quantitatively evaluated in mutant sciatic and dermal
nerves; (iv) qualitative ultrastructural analysis. Morpho-
Fig. 1. Intraepidermal and dermal nerve ﬁbers in WT mice. A small-
sterilized punch was used to taken glabrous skin from the lateral aspect
of the palm (A). Parafﬁn sections (B) of control skin stained with anti-
PGP9 show intraepidermal (arrowhead) and dermal (arrows) nerve fas-
cicles. Transverse semithin sections of small nerve bundles (C, arrow-
head) run perpendicular to the surface of the skin and large nerve bun-
dle run parallel to the surface of skin (D, arrows). Normal myelinated
nerve ﬁbers within a large nerve bundle are shown (E and F). Electron
microscopic analysis shows transverse normal nerve ﬁber (G, asterisk
marks the axon), normal axonal structure, including neuroﬁlaments and
microtubules. At high magniﬁcation (H) the periodicity of compact mye-
lin appears normal and the myelinated ﬁber has a tightly apposed basal
lamina (arrowheads). Quantiﬁcation and diameter distribution of myelin-
ated ﬁbers in sciatic and dermal nerves as a percentage of the total num-
ber of myelinated ﬁbers (I). Transverse semithin sections of dermal nerve
after sciatic nerve cut: a large bundle with signs of axonal degeneration
(J, arrows) and severe ﬁber loss, a small intraepidermal fascicle with
complete loss of ﬁbers (K, arrowhead).
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GLIAmetric analysis was performed as previously described
(Triolo et al., 2006) and data were analyzed via Student’s
t-test (independent for intertime point analysis and
paired for sciatic versus dermal nerve comparisons). The
threshold for statistical signiﬁcance was set at P < 0.05.
RESULTS
Myelinated Fibers in WT Dermal Nerve
The main phenotypic features of the mouse models used
in this study are reported in Table 1. We ﬁrst validated the
SB technique in WT mice. Skin innervation was identiﬁed
by immunohistochemistry for axons with anti-PGP9.5 anti-
body. Both superﬁcial unmyelinated intraepidermal nerve
ﬁbers and also some deep fascicles were detected in all sam-
ples (Fig. 1B). These nerves and fascicles contained not only
unmyelinated, but also larger myelinated ﬁbers. The large
nerve bundles were usually located in the deep portion of
the dermis and traveled parallel to the surface of the skin.
The number of bundles varied from one biopsy to another;
however, the number and size of bundles was similar among
biopsies taken from the same site, as compared to another.
Semithin section analysis conﬁrmed the presence of small
superﬁcial dermal bundles with few myelinated ﬁbers, run-
ning perpendicular to the skin, and large dermal bundles
(Fig. 1C,D), containing many myelinated ﬁbers, located
between the dermis and sub cutis close to large vessels and
adipocytes. Ultrastructural analysis of these nerve ﬁbers
showed normal axons and myelin sheaths (Fig. 1G,H).
Morphometric analysis of dermal nerves showed a dis-
tribution of nerve ﬁbers similar to sciatic nerve. The
dermal nerve ﬁber density was 9,259 6 900 per mm
2
with a G-ratio of 6.6 6 0.2, with prevalence of small
ﬁbers of diameter less than 5 lm (45%) (Fig. 1I). It is
known that nerve ﬁbers innervating the plantar pad of
the hind paw derive from sciatic nerve. We conﬁrmed
these data as sciatic nerve transection was followed by
degeneration of nerve ﬁbers in pad SB from the ipsilat-
eral limb (Fig. 1J,K). These data suggest that dermal
nerves are easily sampled and possess morphological
features similar to those of sciatic nerve.
Myelin and Axonal Damage in Dermal Nerves
from Animal Models of Hereditary Neuropathies
To compare changes in dermal nerves from pad SB to
sciatic nerves, we evaluated mutant mice at different
ages (Table 2). We detected dermal nerve abnormalities
in all mouse models, which resembled the alterations in
sciatic nerves. However, pad SB revealed additional
abnormal features, such as axonal damage, not previ-
ously detected by sciatic nerve examination (Table 2).
These mice are presented in detail below.
Mice overexpressing P0 protein developed a severe neu-
ropathy similar to CHN in humans (Wrabetz et al., 2000).
P0 overexpression parallels severity of nerve phenotype,
among the low (Tg80.3), medium (Tg80.4), and high copy
number (Tg80.2). Thus, the 80.2 line manifests severe
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GLIAdysmyelination, hypomyelination and bundles of
unsorted, larger diameter axons (data not shown) (Wra-
betz et al., 2000). Abnormalities were also present in
Tg80.4, and less so in Tg80.3 animals. In this study, to
explore whether distal nerve abnormalities are more pro-
nounced, we analyzed the moderately affected Tg80.4.
Tg80.4 sciatic nerves were hypomyelinated and hyper-
myelinated. Ultrastructural analysis showed dysmyelina-
tion (Fig. 2A–E). No abnormalities in axons or axonal
degeneration were observed at 6 and 12 months. In con-
trast, in SB dermal nerves at 6 months, we observed an
important reduction of nerve ﬁbers associated with axo-
nal degeneration, not previously detected on sciatic nerve
(Fig. 2G–J). Dysmyelinated axons in these mutants have
Fig. 2. CHN mice develop a severe dysmyelinating neuropathy
with axonal degeneration. Sciatic nerve (A–F): transverse semithin
sections showed some hypomyelinated ﬁbers with some naked large
caliber axons (A and B, arrows); some ﬁbers presenting hypermyelina-
tion were observed (B, arrowheads). Ultrastructural analysis showed
Schwann cell surrounding naked large caliber axons surrounded by
redundant basal lamina (C–E). At high magniﬁcation a normal organi-
zation of neuroﬁlaments in the axon was observed (F). n5 Schwann
cell nucleous; a 5 axon. Transverse semithin section of the dermal
nerve shows loss of myelinated nerve ﬁbers and signs of acute axonal
degeneration (G, arrows). Ultrastructural analysis conﬁrmed the pres-
ence of axonal degeneration (J) with a macrophage inside the basal
lamina and shows dysmyelination (H and I); Schwann cell surrounded
naked axon, surrounded by redundant basal lamina (I, arrowheads).
At high magniﬁcation disorganization of the axon was observed (K):
transverse section of a dermal axon of a 12-month-old mouse, showing
massive accumulation of ﬁlamentous aggregates and loss of microtu-
bules.
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GLIAmore densely packed NFs, compared to axons in the sci-
atic nerve (Fig. 2K). Thus, these are typical features of
progressive, length-dependent CHN neuropathy.
P0-myc mice resemble a subtype of CMT1B with tom-
acula formation (Previtali et al., 2000). P0myc/Tg88.4
mice have mild P0 overexpression. Nonetheless, trans-
verse semithin sections revealed not only diffuse hypo-
myelination, but also abnormally outfolded myelin
sheaths at 6 months (tomacula-like, 2% of ﬁbers),
increasing in number with age (Fig. 3). Loss of ﬁbers
and signs of axonal degeneration were not present at
12 months in sciatic nerve. In pad SB, we observed simi-
lar nerve abnormalities although myelin disruption and
tomacula were more numerous. Morphometrical analysis
showed lower ﬁber density and a higher percentage of
tomacula-like ﬁbers in dermal nerves (Table 3), reaching
a high level of statistical signiﬁcance at 9 months.
We previously reported that both P0S63del and
P0S63C mice develop evident demyelinating neuropathy,
with characteristics respectively of CMT1B and DSS
(Wrabetz et al., 2006). Lines with higher expression de-
velop more obvious defects. Semithin section analysis of
sciatic nerve from 12-month-old S63del and S63C mice
show dysmyelinating neuropathy, consisting of hypomye-
lination and demyelination with onion bulb formation
(greater in S63del), without signs of axonal damage. To
examine whether a more pronounced phenotype would
be detected in the distal part of PNS, we chose line
129.4 and line 130.3, each with milder sciatic nerve phe-
notypes. Analysis of 6-month-old S63del Tg129.4 mice,
revealed hypomyelination and more onion bulbs than
S63C Tg130.3, which manifested hypomyelination and
less onion bulbs in sciatic nerve (see Fig. 4). In pad SB,
in both lines, we conﬁrmed dysmyelinating ﬁndings, but
features were more severe and frequent than in sciatic
nerve, including demyelination and onion bulbs in both
lines. We also noted reduced numbers of myelinated
ﬁbers and occasional axonal degeneration (see Fig. 4).
The axonal damage might result from the proximal pro-
cess of dysmyelination.
Fig. 3. Transverse semithin section of P0-myc mice (CMT1B): in sciatic nerve (A and C) few tomacula forma-
tion (arrows) and hypomyelinated large caliber axons are present (A and C, arrowhead); many tomacula (B and
D arrows) and numerous thinly myelinated (arrowhead) ﬁbers are present in dermal nerves, increasing with age.
TABLE 3. Quantitative Data: Comparison of Sciatic Nerve and Pad Skin Biopsies
M
Fibers # mm
2, mean (SD)
% reduction
% of nerve ﬁbers abnormalities, mean (SD)
% difference Sciatic nerve Dermal nerve Sciatic nerve Dermal nerve
CMT1B tomacular: P0-myc 6 8919 (1110) 7961 (1438) 9.59
ns 1.90 (0.20) 6.87 (1.45) 4.97*
9 7986 (179) 5335 (193) 26.51*** 3.30 (0.53) 8.33 (0.51) 5.03***
CMT4B Mtmr2-null 2 9372 (417) 8438 (340) 9.34*** 6.00 (5.80) 11.23 (0.75) 5.23**
6 8742 (646) 7236 (668) 15.06*** 16.47 (1.36) 33.60 (2.90) 17.13*
M, months; ns, not signiﬁcant; *P < 0.05; **P < 0.005; ***P < 0.0005.
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GLIASchwann cell Mtmr2-null mice show myelin outfold-
ings and redundant loops of myelin increasing with age
(5% of myelinated ﬁbres at 2 months, 10% at 4 months,
16% at 6 months, and 26% at 12 months) (Bolino et al.,
2004; Bolis et al., 2005). The complexity of the dysmyeli-
nating neuropathy also increased with age as revealed
by counting the number of ﬁbers showing three or more
satellite loops. In this study, semithin section analysis
conﬁrmed the dysmyelinating neuropathy at 2 and 6
months (see Fig. 5). The analysis of nerves from pad SB
showed a more severe neuropathy with more numerous
signs of dysmyelination and myelin outfoldings (see Fig.
5). In addition, we noted reduced numbers of myelinated
ﬁbers, occasional degenerating axons and more evident
Fig. 4. DSS (S63C, 6-months-old). Semithin section of sciatic nerve
showed many ﬁbers with thin myelin (hypomyelination) (A, arrows);
more evident in dermal nerves: hypomyelination with naked axons (B
and C, arrowhead) and onion bulb formations (B and C, arrows).
CMT1B (S63del). Semithin section of sciatic nerve (D) showed severe
hypomyelination with many large caliber axons without myelin (D,
arrows); semithin section of dermal nerve (E) showed a severe hypo-
myelination (arrows) and ﬁber loss. Immunohistochemistry on trans-
verse dermal nerves from 6-months-old S63Del mice using anti-NF (F–
H, red, to recognize axons), anti-P0 antibody (F, green, to recognize
compact myelin); anti-MAG antibody (G, green) to detect noncompact
myelin and anti-Caspr (H, green), which identiﬁes paranodal domains
in longitudinal section: most ﬁbers are positive for P0 (F, arrows) but
some large ﬁbers had no detectable P0 staining (arrowhead) in S63del
mice; in MAG-stained transverse sections, few ﬁbers were stained
around their entire circumference (G, arrows), but others were negative
for MAG (arrowhead); in H, Caspr dislocated into paranodes (arrow-
head) and internodal region (arrows).
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GLIAonion bulbs at 6 months. Dermal nerve ﬁber density was
signiﬁcantly lower as compared to sciatic nerve at both
2 and 6 months of age (Table 3). The number of ﬁbers
containing myelin outfoldings and loops was signiﬁ-
cantly higher in dermal nerves of Mtmr2-null mice
examined at 2 and 6 months (Table 3), with more com-
plex myelin outfoldings, as compared to sciatic nerves.
These data indicate that the morphological alterations
are length dependent.
a6b4 integrin and dystroglycan cooperate to stabilize
the myelin sheaths (Moore et al., 2002). Nodari et al.
(2008) showed that sciatic nerves from b4 integrin/dys-
troglycan double mutants present abnormally folded
myelin, with abnormal loops, infolding, and outfolding,
which increase in number with age. We conﬁrmed these
ﬁndings in sciatic nerve. SB, however, revealed a more
severe neuropathy with abnormal loops, infolding, and
outfolding and associated demyelination and ﬂorid for-
mation of onion bulbs, indicating chronic cycles of demy-
elination and remyelination. In distal axons at 12
months, NFs were closely packed and unevenly distrib-
uted, in contrast with the regularly spaced, parallel
arrays of NFs in axons in the sciatic nerve (see Fig. 6).
Distal SB axons also revealed evident vesicle accumula-
tion and mitochondria abnormalities. Fiber loss was
present (50% loss) associated with axonal degeneration.
Thus, this mouse model showed all the features of pro-
gressive, length-dependent MDCN associated neuropa-
thy as in human (Di Muzio et al., 2003).
Molecular Changes in Dermal Nerves
We performed immunohistochemical studies to investi-
gate molecular changes in axons and Schwann cells of
dermal nerves from CMT1B and MDCN mice. SB from
CMT1B (S63del) mice demonstrate a severe dysmyeli-
nating neuropathy (above). By immunohistochemical
analysis, we conﬁrmed a variation in the intensity of P0
staining among different ﬁbers (Fig. 4F) with few ﬁbers
showing normal staining. Many P0-negative ﬁbers were
observed. In MAG-stained sections, usually, ﬁbers had
abnormal reaction or no detectable signal (Fig. 4G). Fur-
thermore, in these mice we documented an abnormal
localization of Caspr, a paranodal marker, in longitudi-
nal sections with a diffusion of Caspr into the internodes
(Fig. 4H), conﬁrming the importance of a normal myelin
for the integrity of the nodal/paranodal region.
We have shown that in the distal aspects of MDCN
mice axons are signiﬁcantly altered with abnormal spac-
ing of NFs. It is known that axonal properties, such as
spacing and phosphorylation of NFs are dependent on
glial characteristics and as has been described, for
example, in MAG-deﬁcient mice (Yin et al., 1998). First,
we showed in MAG-stained sections from MCDN mutant
nerves an abnormal pattern of expression that was
irregular among and within individual ﬁbers. Some
large axons were negative for MAG staining and others
manifested an irregular staining with many dots corre-
sponding to folded myelin, abnormal loops, and outfold-
Fig. 5. Excessive myelin outfolding in dermal nerves of Mtmr2-null mice. Transverse semithin sections of
Mtmr2-null sciatic nerves (A and B) and dermal nerves (C and D). Arrows indicate ﬁbers with myelin outfold-
ings. Myelin outfoldings are more evident and numerous in dermal nerves (C and D), increasing with age.
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mutants (MCDN) mice: few ﬁbers with myelin abnormalities are pres-
ent in sciatic nerve (A, arrows); abnormalities are severe in dermal
nerve (C and D): numerous abnormal loops, infoldings and outfoldings
(arrows) are present. Electron microscopy analysis of dermal nerves of
a 12-month-old mouse conﬁrmed chronic remyelination (onion bulbs,
E–G). Electron microscopy showed neuroﬁlamentous accumulations
and enlarged mitochondria with varying degrees of loss of structural in-
tegrity (H) compared to sciatic nerve (B). Immunocytochemical localiza-
tion of MAG in cross sections from MCDN mice (I and J); MAG stain-
ing (green) is variable in intensity and localization and often absent
around axons (red) (I, arrow) and in others less intense (I, arrowhed),
in J, periaxonal spots of staining (arrowhead), corresponding to myelin
loops and outfoldings. Double immunohistochemistry on transverse der-
mal nerves stained for poorly or nonphosphorylated NF-H (red) and
phosphorylated NF-H (green) in WT (K and M) and MCDN (I and N)
dermal nerves: double staining shows intense reaction for phosphoryl-
ated NF-H in WT mice (K and M, arrows), whereas high positivity for
nonphosphoryated NF-H in MCDN dermal nerves (I and N, arrows).
Note the green staining for unmyelinated axons (N, arrowhead).
Images were acquired using the same settings in WT and MCDN der-
mal nerves.
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by immunohistochemistry a reduction of NF-H phospho-
rylation status in dermal nerve axons in this mutant,
conﬁrming the importance of the link between the
Schwann cell phenotype and axonal properties.
DISCUSSION
SB has been exploited to demonstrate the decreased
number of epidermal unmyelinated nerve ﬁbers in
patients with diabetes (Kennedy et al., 1996; Polydefkis et
al., 2001), HIV infection (Polydefkis et al., 2002), and small
ﬁber sensory neuropathy (Devigili et al., 2008; Holland et
al., 1997; Kennedy and Wendelschafer-Crabb, 1993). It has
also been used to obtain tissue samples from experimental
models of peripheral neuropathies such as diabetic and
traumatic neuropathy (Giatti et al., 2009; Navarro et al.,
1997; Wu et al., 2001). Here, we studied the histopathologi-
cal alterations in models of hereditary neuropathies using
punch SB from the hind foot pad and we compared it to
the traditional sciatic nerve examination.
Dermal Myelinated Nerves Show Morphological
Features Similar to Those of Sciatic Nerve
SB was found to be safe, even for mice with very severe
neuropathy, reproducible and fast, and usually this method
involves gentle and brief handling; thus exposing the ani-
mals to minimal stress. An important beneﬁt is that the
specimen includes not only the intraepidermal nerve ﬁbers,
but also a whole cross section of the deep dermal nerves
with myelinated ﬁbers. SB gives sufﬁcient nerve tissue for
histopathological analyses and produces good quality
results that allow the monitoring and grading of the neu-
ropathy. We have shown that myelinated nerve ﬁbers can
be easily and routinely identiﬁed and evaluated in SB: der-
mal nerves appeared by light and electron microscopy iden-
tical to myelinated nerve ﬁbers obtained in sciatic nerve
analysis. They represent mixed sensory-motor ﬁbers, as
suggested by morphometric analysis where they revealed a
composition very similar to that of sciatic nerve. Further-
more, they are distal branches of sciatic nerve, as demon-
strated by all ﬁbers undergoing axonal degeneration after
transection of sciatic nerve. Taken together, the results
demonstrate that the structure and organization of myelin-
ated nerves in SB is similar to those of the sciatic nerves.
This opens a new, noninvasive approach to study and follow
transgenic or genetically engineered strains of mice that
serve as animal models for hereditary neuropathies.
SB Is a Tool to Assess the Neuropathy Severity
and Progression
SB revealed many of the morphological abnormalities
described in mouse models of hereditary neuropathies.
Evaluation of large deep dermal nerves were able to
identify hypomyelination in CHN (Wrabetz et al., 2000),
myelin abnormalities such as onion bulbs and tomacula
in CMT1B, DSS (Previtali et al., 2000; Wrabetz et al.,
2006) and MDCN (Nodari et al., 2008) and myelin out-
folding in CMT4B (Bolino et al., 2004; Bolis et al., 2005).
Our SB approach provided reproducible results, allowing
the degree of neuropathy and severity to be scored by
light and electron microscopy studies. Moreover SB was
less invasive than sciatic nerve investigation, which
requires surgery and the death of the mouse. Instead,
we showed that SB can be repeated at least two times,
in WT animals, and tissue changes could be reliably fol-
lowed in one animal. In this way, the number of animals
employed and costs can be reduced. In all types of mu-
tant mice examined here, SB revealed similar, yet more
severe and relevant signs of the underlying pathology,
suggesting that punch SB could be performed in alterna-
tive to sciatic nerve examination in animal models of he-
reditary peripheral neuropathies.
We mostly studied models of demyelinating peripheral
neuropathies where ﬁber loss and signs of axonal degen-
eration are very difﬁcult to detect in the sciatic nerve.
In hereditary neuropathies, a frequent cause of disabil-
ity is progressive axonal degeneration and ﬁber loss
from a dying back process (Barisic et al., 2008; Kamholz
et al., 2000; Krajewski et al., 2000; Shy, 2004). We and
others have previously studied different distal sites of
peripheral nerve damage, such as the nerves of the toe
(Bolino et al., 2004; Frei et al., 1999; Wrabetz et al.,
2000). The limit of this procedure, in our experience,
was that the nerve is very thin with small fascicles,
variable branching along the proximal-distal axis, and
higher susceptibility to traumatic injury. Instead, pad
SB was more easily able to reveal axonal degeneration,
not previously detected by sciatic nerve examination. In
our models, punch biopsy revealed an important reduc-
tion of ﬁbers, increase numbers of abnormalities, ovoids
of degeneration suggesting an active axonal damage in
the distal part of the PNS. Quantitative data conﬁrmed
the gradient of severity of neuropathology from distal to
proximal along the ﬁber length. This provides further
evidence that dysmyelination causes secondary axonal
damage in models of hereditary neuropathies (Frei
et al., 1999).
The maintenance of the Schwann cell-axon unit is
essential for axonal integrity. Mice null for MAG, an ad-
hesion molecule that is localized in noncompact myelin,
show an abnormal NF network and axonal degeneration
in motor nerves, suggesting that MAG is essential for
maintenance of both myelin and axonal integrity (Yin et
al., 1998). Here, we observed that distal axons in P0 mu-
tant and MDCN mice have abnormalities such as densely
packed NFs. SB provided information on the molecular
architecture of dermal nerve ﬁbers, in particular showing
a decrease in NFs phosphorylation status of distal axons,
further supporting the concept that an impaired Schwann
cell phenotype can lead to altered axonal properties in
demyelinating neuropathy (Martini, 2001). In addition,
we found an increased numbers of mitochondria and
intra-axonal vesicles, suggesting an impairment of an-
terograde axonal transport. One possibility is that shorter
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could increase apparent axonal abnormalities due simply
to increase numbers of nodes of Rancier where mitochon-
dria and intra-axonal vesicles are typically found. How-
ever, we doubt this as we found such changes in regions
of the axon without morphological features of node/para-
node.
A common hallmark of many neurodegenerative dis-
eases (Cleveland, 1999; Julien and Beaulieu, 2000),
including the hereditary axonal neuropathies (Bomont
et al., 2000; Lupski, 2000; Mersiyanova et al., 2000), is
disorganization of the NF network with impairment of
axonal transport. Transport of organelles and molecules
assembled in the neuronal cell body must occur over
signiﬁcant distances in long axons. Furthermore, NFs
accumulation or changes may slow axonal transport and
perturb the function of microtubules, which are key
organelles of intracellular transport (La Monte et al.,
2002; Puls et al., 2003). We found abnormalities preva-
lently in SB, suggesting an impairment of axonal trans-
port that could probably contributes signiﬁcantly to the
ultimate degeneration of axons.
Our ﬁndings are in agreement with the results
obtained from SB in patients with CMT hereditary neu-
ropathies (Li et al., 2005; Sabet et al., 2006). In fact, der-
mal nerves from CMT1A and CMT1X patients not only
show abnormalities previously detected in sural nerve
biopsies, but also detect other abnormal ﬁndings previ-
ously unreported in CMT. Similarly, in dermal nerves
from SB, we observed axonal pathology undetected in
our mouse models of hereditary neuropathies. Our data
demonstrate that SB is a valid approach to reveal the
amount of axonal loss in the distal part of the PNS. In
conclusion, SB might be useful to evaluate pathological
abnormalities in many animal models of dysmyelinating
neuropathies.
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